STAT3 and polycystic ovary syndrome: Our study was the first to demonstrate, using a non-metabolic PCOS mouse model, that IL-22 directly improves ovarian function via its classical downstream molecule STAT3, and does not rely on the regulation of systemic metabolic homeostasis.